Inovio Pharmaceuticals Inc vs ThredUp Inc — how do they compare? Inovio Pharmaceuticals Inc trades at $0.91 (market cap $78.67M), while ThredUp Inc trades at $3.17 (market cap $405.82M). The key difference: ThredUp Inc is far larger — about 5.2× Inovio Pharmaceuticals Inc's market cap, and Inovio Pharmaceuticals Inc is trading nearer its 52-week high, ThredUp Inc nearer its low. Which is the better fit depends on your goals.
| INO | TDUP | |
|---|---|---|
Market Cap | $78.67M | $405.82M |
Sector | Health | Consumer Cyclical |
52-Week High | $2.87 | $12.08 |
52-Week Low | $0.66 | $3.08 |
Enterprise Value | $50.00M | $404.00M |
Trailing returns across standard periods
Latest headlines on both assets
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →ThredUp Inc is an online resale platform for women and kids apparel, shoes, and accessories. It generates revenue from items that are sold to buyers through the website, mobile app, and RaaS partners.
Read more on TDUP →